80 related articles for article (PubMed ID: 14767546)
41. Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.
Kunze D; Wuttig D; Fuessel S; Kraemer K; Kotzsch M; Meye A; Grimm MO; Hakenberg OW; Wirth MP
Anticancer Res; 2008; 28(4B):2259-63. PubMed ID: 18751404
[TBL] [Abstract][Full Text] [Related]
42. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
43. Apoptosis induced by short hairpin RNA-mediated STAT6 gene silencing in human colon cancer cells.
Zhang MS; Zhou YF; Zhang WJ; Zhang XL; Pan Q; Ji XM; Luo ZG; Wu JP
Chin Med J (Engl); 2006 May; 119(10):801-8. PubMed ID: 16732981
[TBL] [Abstract][Full Text] [Related]
44. [Inhibition of proliferation in MCF-7 breast cancer cells by plasmid-based siRNA targeting to oncogene c-myc].
Zhou CH; Peng XD; Wu J; Zhang P; Zhao ZR; Wei DP; Zhang CJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):373-7. PubMed ID: 18575318
[TBL] [Abstract][Full Text] [Related]
45. [Apoptosis increased by bcl-2 antisense ODN in MCF-7 cell line].
Zheng J; Yao Z
Zhonghua Wai Ke Za Zhi; 1999 Jul; 37(7):418-20. PubMed ID: 11829877
[TBL] [Abstract][Full Text] [Related]
46. The effects of CD59 gene as a target gene on breast cancer cells.
Li B; Chu X; Gao M; Xu Y
Cell Immunol; 2011; 272(1):61-70. PubMed ID: 22000275
[TBL] [Abstract][Full Text] [Related]
47. A novel T7 RNA polymerase autogene for efficient cytoplasmic expression of target genes.
Brisson M; He Y; Li S; Yang JP; Huang L
Gene Ther; 1999 Feb; 6(2):263-70. PubMed ID: 10435111
[TBL] [Abstract][Full Text] [Related]
48. Combination silencer RNA (siRNA) targeting Bcl-2 antagonizes siRNA against thymidylate synthase in human tumor cell lines.
Pandyra AA; Berg R; Vincent M; Koropatnick J
J Pharmacol Exp Ther; 2007 Jul; 322(1):123-32. PubMed ID: 17452420
[TBL] [Abstract][Full Text] [Related]
49. Development of siRNA expression vector utilizing rock bream beta-actin promoter: a potential therapeutic tool against viral infection in fish.
Zenke K; Nam YK; Kim KH
Appl Microbiol Biotechnol; 2010 Jan; 85(3):679-90. PubMed ID: 19685238
[TBL] [Abstract][Full Text] [Related]
50. Endothelial cell DNA transfer and expression using petri dish electroporation and the nonreplicating vaccinia virus/T7 RNA polymerase hybrid system.
Lewis E; Rudo T; St John MR; Chu J; Heinze A; Howard B; Engleka K
Gene Ther; 1999 Sep; 6(9):1617-25. PubMed ID: 10490772
[TBL] [Abstract][Full Text] [Related]
51. Dual gene targeted multimeric siRNA for combinatorial gene silencing.
Lee SH; Mok H; Jo S; Hong CA; Park TG
Biomaterials; 2011 Mar; 32(9):2359-68. PubMed ID: 21183215
[TBL] [Abstract][Full Text] [Related]
52. Effective treatment of leukemic cell lines with wt1 siRNA.
Glienke W; Maute L; Koehl U; Esser R; Milz E; Bergmann L
Leukemia; 2007 Oct; 21(10):2164-70. PubMed ID: 17690705
[TBL] [Abstract][Full Text] [Related]
53. Modulation of dendritic cell maturation and function by siRNA-bearing 5'-triphosphate.
Sioud M
Methods Mol Biol; 2010; 629():395-404. PubMed ID: 20387164
[TBL] [Abstract][Full Text] [Related]
54. Tumor Targeting Gene Vector for Visual Tracking of Bcl-2 siRNA Transfection and Anti-Tumor Therapy.
Sun W; Liu XY; Ma LL; Lu ZL
ACS Appl Mater Interfaces; 2020 Mar; 12(9):10193-10201. PubMed ID: 32045197
[TBL] [Abstract][Full Text] [Related]
55. Design of double-walled carbon nanotubes for biomedical applications.
Neves V; Heister E; Costa S; Tîlmaciu C; Flahaut E; Soula B; Coley HM; McFadden J; Silva SR
Nanotechnology; 2012 Sep; 23(36):365102. PubMed ID: 22914449
[TBL] [Abstract][Full Text] [Related]
56. An alternative approach for screening active bam HI variants: overexpression in T-7 RNA polymerase based system.
Acharya AS; Roy KB
Indian J Biochem Biophys; 2001 Oct; 38(5):303-8. PubMed ID: 11886077
[TBL] [Abstract][Full Text] [Related]
57. Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review.
Jagani H; Kasinathan N; Meka SR; Josyula VR
Artif Cells Nanomed Biotechnol; 2016 Aug; 44(5):1212-21. PubMed ID: 25801037
[TBL] [Abstract][Full Text] [Related]
58. Time depended Bcl-2 inhibition might be useful for a targeted drug therapy.
Talaiezadeh A; Jalali F; Galehdari H; Khodadadi A
Cancer Cell Int; 2015; 15():105. PubMed ID: 26535028
[TBL] [Abstract][Full Text] [Related]
59. Molecular Engineering of Functional SiRNA Agents.
Batra N; Tu MJ; Yu AM
ACS Synth Biol; 2024 Jun; 13(6):1906-1915. PubMed ID: 38733599
[TBL] [Abstract][Full Text] [Related]
60. Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy.
Wu JB; Tang YL; Liang XH
Onco Targets Ther; 2018; 11():6901-6909. PubMed ID: 30410348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
